RECANATI LEON
SEC Form 4 insider trading activity
RECANATI LEON has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Aug 13, 2026.
On the most recent filing, RECANATI LEON is listed as Director at Evogene Ltd. Inside the rolling window, RECANATI LEON reported 2 open-market purchases totaling $692K in EVGN and no open-market sales. The largest disclosed transaction in the window is a purchase of 800,000 EVGN shares on Aug 4, 2026, worth $400K.
Companies traded
Other insiders at EVGN
Insider Buying
$692K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has RECANATI LEON made?
RECANATI LEON has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does RECANATI LEON trade?
RECANATI LEON has filed SEC Form 4 disclosures for 1 company, including EVGN.
When was RECANATI LEON's most recent SEC Form 4 filing?
RECANATI LEON's most recent SEC Form 4 filing on Tracefour is dated Aug 13, 2026.
What is RECANATI LEON's total buy and sell value in the current window?
Inside the rolling retention window, RECANATI LEON bought $692K and sold $0 based on SEC Form 4 filings.
What was RECANATI LEON's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 800,000 EVGN shares on 2026-08-04, worth $400K, per SEC Form 4 filings.